Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

27.52
Delayed Data
As of Jun 25
 +0.02 / +0.07%
Today’s Change
10.41
Today|||52-Week Range
28.46
+121.58%
Year-to-Date
No recent news for Arrowhead Pharmaceuticals Inc.

Today’s Trading

Previous close27.50
Today’s open27.69
Day’s range27.24 - 27.90
Volume1,483,692
Average volume (3 months)1,944,977
Market cap$2.7B
Data as of 4:00pm ET, 06/25/2019

Growth & Valuation

Earnings growth (last year)-38.51%
Earnings growth (this year)+201.85%
Earnings growth (next 5 years)--
Revenue growth (last year)-48.60%
P/E ratio393.1
Price/Sales99.33
Price/Book25.99

Competitors

 Today’s
change
Today’s
% change
MEDPMedpace Holdings Inc+0.32+0.52%
RGNXRegenxbio Inc+0.15+0.30%
FGENFibroGen Inc-1.27-2.92%
CDXSCodexis Inc-0.31-1.65%
Data as of 4:00pm ET, 06/25/2019

Financials

Next reporting dateAugust 7, 2019
EPS forecast (this quarter)$0.24
Annual revenue (last year)$16.1M
Annual profit (last year)-$54.5M
Net profit margin-337.32%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Christopher Richard Anzalone
Chief Operating Officer
Bruce D. Given
Corporate headquarters
Pasadena, California

Forecasts